1-7 of 7
Daniel R. Henderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial of CV706, a Replication-competent, PSA Selective Oncolytic Adenovirus, for the Treatment of Locally Recurrent Prostate Cancer following Radiation Therapy

Theodore L. DeWeese, Henk van der Poel, Shidong Li, Bahar Mikhak, Renee Drew, Marti Goemann, Ulrike Hamper, Robert DeJong, Nicholas Detorie, Ronald Rodriguez, Thomas Haulk, Angelo M. DeMarzo, Steven Piantadosi, D. C. Yu, Yu Chen, Daniel R. Henderson, Michael A. Carducci, William G. Nelson, Jonathan W. Simons
Journal: Cancer Research
Cancer Res (2001) 61 (20): 7464–7472.
Published: 01 October 2001
View article titled, A Phase I Trial of CV706, a Replication-competent, PSA Selective Oncolytic Adenovirus, for the Treatment of Locally Recurrent Prostate Cancer following Radiation Therapy
Open the PDF for A Phase I Trial of CV706, a Replication-competent, PSA Selective Oncolytic Adenovirus, for the Treatment of Locally Recurrent Prostate Cancer following Radiation Therapy in another window
Journal Articles

A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin

Yuanhao Li, De-Chao Yu, Yu Chen, Pinky Amin, Hong Zhang, Natalie Nguyen, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (17): 6428–6436.
Published: 01 September 2001
View article titled, A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin
Open the PDF for A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin in another window
Journal Articles

CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity

Yu Chen, Theodore DeWeese, Jeanette Dilley, Yiwei Zhang, Yuanhao Li, Nagarajan Ramesh, Jake Lee, Rukmini Pennathur-Das, John Radzyminski, Joseph Wypych, Dominic Brignetti, Sara Scott, Jennifer Stephens, David B. Karpf, Daniel R. Henderson, De-Chao Yu
Journal: Cancer Research
Cancer Res (2001) 61 (14): 5453–5460.
Published: 01 July 2001
View article titled, CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity
Open the PDF for CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity in another window
Journal Articles

Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel

De-Chao Yu, Yu Chen, Jeanette Dilley, Yuanhao Li, Millicent Embry, Hong Zhang, Natalie Nguyen, Pinky Amin, Joe Oh, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (2001) 61 (2): 517–525.
Published: 01 January 2001
View article titled, Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel
Open the PDF for Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel in another window
Journal Articles

The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts

De-Chao Yu, Yu Chen, Monica Seng, Jeanette Dilley, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (1999) 59 (17): 4200–4203.
Published: 01 September 1999
View article titled, The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts
Open the PDF for The Addition of Adenovirus Type 5 Region E3 Enables Calydon Virus 787 to Eliminate Distant Prostate Tumor Xenografts in another window
Journal Articles

Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy

De-Chao Yu, Gordon T. Sakamoto, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (1999) 59 (7): 1498–1504.
Published: 01 April 1999
View article titled, Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy
Open the PDF for Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy in another window
Journal Articles

Prostate Attenuated Replication Competent Adenovirus (ARCA) CN706: A Selective Cytotoxic for Prostate-specific Antigen-positive Prostate Cancer Cells

Ron Rodriguez, Eric R. Schuur, Ho Yeong Lim, Gail A. Henderson, Jonathan W. Simons, Daniel R. Henderson
Journal: Cancer Research
Cancer Res (1997) 57 (13): 2559–2563.
Published: 01 July 1997
View article titled, Prostate Attenuated Replication Competent Adenovirus (ARCA) CN706: A Selective Cytotoxic for Prostate-specific Antigen-positive Prostate Cancer Cells
Open the PDF for Prostate Attenuated Replication Competent Adenovirus (ARCA) CN706: A Selective Cytotoxic for Prostate-specific Antigen-positive Prostate Cancer Cells in another window